AVODART

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Germany, Ecuador, Estonia, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Malta, Mexico, Netherlands, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug AVODART contains one active pharmaceutical ingredient (API):

1 Dutasteride UNII O0J6XJN02I - DUTASTERIDE

Dutasteride reduces circulating levels of dihydrotestosterone (DHT) by inhibiting both type 1 and type 2, 5α-reductase isoenzymes which are responsible for the conversion of testosterone to DHT. Read about Dutasteride

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
Avodart 0.5mg soft capsules	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G04CB02	Dutasteride	G Genito urinary system and sex hormones → G04 Urologicals → G04C Drugs used in benign prostatic hypertrophy → G04CB Testosterone-5-alpha reductase inhibitors
Discover more medicines within G04CB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10095H, 5468T
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 510610501118215, 510610502114213, 510610503110211
Country: CA	Health Products and Food Branch	Identifier(s): 02247813
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00706059, 00805407, 00805413, 02182353, 02185587, 02329856, 03112314, 03125050, 03202916, 03780694, 03929647, 03929682, 04114686, 04114692, 04172962, 05961000, 10942217, 11342531, 16134122, 16354970, 16357508, 16357514, 16358436, 16363331, 17263034
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 66-MEE-0214
Country: EE	Ravimiamet	Identifier(s): 1155439, 1155440, 1155451, 1225729, 1262472, 1886328, 1886339, 1886340, 1886351, 1886362
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 012209, 012243
Country: FR	Base de données publique des médicaments	Identifier(s): 60051234, 60429851, 63686819, 65346644
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 138349, 142015, 299793, 43619
Country: HK	Department of Health Drug Office	Identifier(s): 61577
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-357757654
Country: IE	Health Products Regulatory Authority	Identifier(s): 53450, 53470, 53641, 53675
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4646
Country: IT	Agenzia del Farmaco	Identifier(s): 035895010
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1004309, 1016674, 1016675, 1023331, 1023852, 1093398
Country: MT	Medicines Authority	Identifier(s): MA192/02701, PI908/15802A
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 363M2004
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 68195
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100131733
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W67626001, W67626002, W67626003, W67626004, W67626005
Country: SG	Health Sciences Authority	Identifier(s): 12434P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 2113101
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699522196906
Country: US	FDA, National Drug Code	Identifier(s): 0173-0712
Country: ZA	Health Products Regulatory Authority	Identifier(s): 37/21.12/0282